.jpg?format=webp&width=780)
The study aimed to describe the characteristics of contemporary pathways leading to the diagnosis of wild-type transthyretin cardiac amyloidosis (ATTRwt-CA) and their potential association with survival. The study found that half of contemporary ATTRwt-CA diagnoses occur in a heart failure (HF) setting, and patients diagnosed through this pathway had a worse clinical profile and outcome than those diagnosed due to suspected hypertrophic cardiomyopathy or incidentally. However, prognosis remained primarily related to age, NYHA functional class, and comorbidities rather than the diagnostic pathway itself.
Like
Save
Share